| 主題 | 分類 |
|---|
Randomized controlled phase III trial of adjuvant chemo‑immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer
肺癌
文獻出處：Cancer Immunol Immunother.64:51–59.(2015)
Lung adenocarcinoma may be a more susceptive subtype to a dendritic cell-based cancer vaccine than other subtypes of non-small cell lung cancers: a multicenter retrospective analysis
肺癌
文獻出處：Cancer Immunol Immunother.65(9):1099-111.(2016)